- Home
- INBS vs YCBD Comparison
INBS vs YCBD Comparison
Compare INBS & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- YCBD
- Stock Information
- Founded
- INBS 2016
- YCBD 2015
- Country
- INBS United States
- YCBD United States
- Employees
- INBS N/A
- YCBD N/A
- Industry
- INBS Medical Specialities
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- YCBD Health Care
- Exchange
- INBS Nasdaq
- YCBD Nasdaq
- Market Cap
- INBS 8.7M
- YCBD 7.8M
- IPO Year
- INBS N/A
- YCBD N/A
- Fundamental
- Price
- INBS $1.83
- YCBD $0.92
- Analyst Decision
- INBS
- YCBD Strong Buy
- Analyst Count
- INBS 0
- YCBD 1
- Target Price
- INBS N/A
- YCBD $3.00
- AVG Volume (30 Days)
- INBS 159.7K
- YCBD 84.9K
- Earning Date
- INBS 05-13-2025
- YCBD 08-13-2025
- Dividend Yield
- INBS N/A
- YCBD N/A
- EPS Growth
- INBS N/A
- YCBD N/A
- EPS
- INBS N/A
- YCBD N/A
- Revenue
- INBS $2,936,472.00
- YCBD $19,593,146.00
- Revenue This Year
- INBS $280.88
- YCBD $13.00
- Revenue Next Year
- INBS $126.26
- YCBD $10.00
- P/E Ratio
- INBS N/A
- YCBD N/A
- Revenue Growth
- INBS 3.87
- YCBD N/A
- 52 Week Low
- INBS $1.00
- YCBD $0.76
- 52 Week High
- INBS $3.00
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- INBS 58.01
- YCBD 46.56
- Support Level
- INBS $1.52
- YCBD $0.81
- Resistance Level
- INBS $1.73
- YCBD $1.00
- Average True Range (ATR)
- INBS 0.14
- YCBD 0.08
- MACD
- INBS -0.02
- YCBD 0.03
- Stochastic Oscillator
- INBS 68.89
- YCBD 57.26
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.